US IPO Week Ahead: Market Slowdown Continues with No IPOs Scheduled
Renaissance Capital2022-03-05
No IPOs are currently scheduled to price in the week ahead, though a few SPACs may join the calendar during the week.
The typical February lull was quieter than expected, with few large filings and no launches after Presidents’ Day in light of the repercussions of war in Europe. There are a number of large issuers waiting in the pipeline once the IPO market becomes more amenable, led by Bausch Health spin-off Bausch + Lomb(BLCO) and Greek yogurt brand Chobani(CHO), which aims to be the latest public benefit corp to go public.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
